Drug Device Combination Products Market
- 2026 年市場規模
- USD 187.1 Bn
- 2033 年預估規模
- USD 312.5 Bn
- 年複合成長率 CAGR
- 7.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Drug Device Combination Products Market, By Products (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, Other Products), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, Other Applications), By End User (Hospitals, Ambulatory Surgical Centres, Other End User), By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)
報告摘要
Global drug device combination products are innovative solutions in the field of healthcare that integrate drugs, devices, and/or biological products. These products combine the therapeutic properties of drugs with the functionality of medical devices, resulting in safer and more effective treatments for patients. The combination of drugs and medical devices allows for targeted and precise delivery of medications, enhancing the efficacy of the treatment. For example, drug-eluting stents release medication directly at the site of a blocked artery, promoting faster healing and reducing the risk of restenosis. drug device combination products offer several advantages over traditional therapies. They can simplify treatment regimens by combining multiple therapies into a single product, reducing the burden on patients and healthcare providers. This can lead to improved patient adherence to treatment plans and better health outcomes.
Market Dynamics
Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.
For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the U.S. live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.
Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.
Key features of the study
• This report provides in-depth analysis of the global drug device combination product market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analystsStakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market
Market Segmentation
• By Products (Revenue, USD Bn, 2021-2033)
o Drug Eluting Stents
o Transdermal Patches
o Infusion Pumps
o Drug Eluting Balloon
o Inhalers
o Other Products
• By Application (Revenue, USD Bn, 2021-2033)
o Cardiovascular
o Diabetes
o Cancer Treatment
o Respiratory Diseases
o Other Applications
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Ambulatory Surgical Centers
o Other End User
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o AbbVie Inc. (Allergan)
o Terumo Corporation
o GlaxoSmithKline PLC
o Novartis AG
o Medtronic PLC
o Abbott Laboratories
o Boston Scientific Corp.
o W.L. Gore & Associates Inc.
o Stryker Corporation Becton
o Becton, Dickinson and Company
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Products
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Drug Device Combination Products Market, By Products, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Drug Eluting Stents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Transdermal Patches
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Infusion Pumps
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Drug Eluting Balloon
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Other Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
5. Global Drug Device Combination Products Market, By Application, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Cancer Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Respiratory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
6. Global Drug Device Combination Products Market, By End User, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Other End User
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
7. Global Drug Device Combination Products Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
AbbVie Inc. (Allergan)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Terumo Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GlaxoSmithKline PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Medtronic PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abbott Laboratories
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Boston Scientific Corp.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
W. L. Gore & Associates Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Stryker Corporation Becton
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Becton, Dickinson and Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們